Antenatal betamethasone: reassuring long-term data.
Maternal steroid injections shortly before premature delivery reduce the risk of neonatal respiratory distress syndrome. A 30-year follow-up study of subjects exposed to betamethasone in utero showed no impact of this treatment on cardiovascular, mental, pulmonary or bone function.
D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007267:Injections; D011247:Pregnancy; D011295:Prenatal Care; D011297:Prenatal Exposure Delayed Effects; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000517:prevention & control
D005938:Glucocorticoids; D003907:Dexamethasone; D001623:Betamethasone